You may have heard of the impact factor. It is a number given to an academic journal (think Nature or The New England Journal of Medicine) which is often erroneously used a proxy for how good the...
Dr. David Franklin’s conscience was bothering him. At first, the job he had secured in 1996 with Parke-Davis, a division of the Warner-Lambert pharmaceutical company, seemed ideal. Armed with a PhD...
The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...
Searching for CBD on the website of the SQDC returns nearly 1,000 search results. The SQDC is the Quebec-government-owned corporation responsible for selling recreational cannabis to the people....
Can you imagine a tooth being extracted without an anesthetic? Or, worse, a limb being amputated? A horrific thought! Yet that was what patients had to contend with until the mid 19th century when...